Judith Sokei, Orsola di Martino, Mary Basse, Nishanth Gabriel, Conner York, Francesca Ferraro, Stephen Sykes. "MTHFD2 is a selective metabolic vulnerability in AML that supports mitochondrial redox homeostasis and venetoclax resistance." Blood, 2025. doi:10.1182/blood-2025-755